XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Return on Equity

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) currently reports a ROE of 27.91%. That is above the Healthcare sector average of 22.01%. Use the charts on this page to explore XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's ROE history and peer comparisons.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's ROE of 27.91% is higher than the Healthcare sector average of 22.01%. That is roughly 26.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's current 27.91% should be judged against Healthcare norms (sector average: 22.01%) and against XOMAP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 27.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A, and consider following XOMAP for alerts when major investors trade the stock.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On ROE, it currently shows 27.91% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XOMAP with unrelated industries.